Our previously published results show that MTA2 serves as a prognostic factor for human cervical cancer [8], renal cancer [12], and hepatocellular carcinoma [9]; however, less is known about the clinical significance of MTA2 in human osteosarcoma patients. This evidence concerns the gene MTA2 and cervical cancer.